U-Factor Holdings Decides to Adopt Toyota's 'WAVEBASE' for Drug Discovery Using Stem Cell Supernatant 'U-Factor® Fluid'
NQ Score
80/100
N1 Content Completeness
9
AI Summary (NQ-processed)
U-Factor Holdings has decided to adopt Toyota Motor's data analysis system 'WAVEBASE' to enhance drug discovery research involving its stem cell supernatant 'U-Factor® fluid.' Implementation is scheduled for April 2026.